/

Empresas

Le

No verificado

Leveragen

Sobre qué escribimos

BiotecnologíaCienciaMercado laboralMultimediaSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa

18/03/2026

Leveragen Announces Collaboration with Daiichi Sankyo to Support Development of Advanced Biologics Using Next-Gen In Vivo Antibody Discovery Platforms

Fuente

Editor

1.00

0

25/02/2026

Leveragen Strengthens Global Intellectual Property Estate with Issuance of Singularity Platform Patent in Japan

Fuente

Editor

1.00

0

25/07/2025

Leveragen and Propeller Bio Announce Strategic Collaboration to Advance Antibody and Protein Therapeutics

Fuente

Editor

1.00

0

12/12/2024

Multimedia

Mercado laboral

Salud

Biotecnología

Ciencia

DPBIO and Leveragen Announce Strategic Partnership to Advance Antibody Discovery

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0